 - link Copy Url
- [  Share on twitter ](https://twitter.com/intent/tweet?text=Gilead and Kite Present: Episode 4 - Delivering Possible https://www.3blmedia.com/markdownify/node/325916?absolute=1&via=3blnews "link to 3 B L Media's Twitter")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/325916?absolute=1 "link to 3 B L Media's Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/325916?absolute=1 "link to 3 B L Media's Facebook")
- [ email Share via email ](mailto:?subject=Gilead and Kite Present: Episode 4 - Delivering Possible&body=ESG News from Gilead Sciences https://www.3blmedia.com/markdownify/node/325916?absolute=1 "Share via email")
 
 

 [Supply Chain &amp; the Circular Economy](/CSR-News/supply-chain-circular-economy)

 # Gilead and Kite Present: Episode 4 - Delivering Possible

 


 

 May 5, 2021 1:05 PM ET

  ![](/sites/default/files/videos/thumbnails/771196/thumbnail-771196_0005.png)

 ▶ 

Video 

  

 

 



 

 

Even under the best circumstances, logistics requires precision and adaptability to be successful. Factor in a cargo of live patient cells, and things become even more critical. A year ago in March, as the pandemic took hold across Europe, severe travel restrictions were implemented – increasing these challenges.

In the latest episode of our ongoing “Possible” series, we hear from Pieter van Hengel, Senior Manager of Supply Chain, Order Management and Logistics for Kite. Pieter, who earlier in his career worked to get food and supplies into war-torn areas, says he has never faced anything as tough in his career. He and his team worked to overcome constantly disrupted supply chains, limited flights and border closings, ensuring that daily shipments of live cells remained on schedule and that the critical needs of people with cancer were met.

Watch other episodes of our “Possible” series [here](https://www.youtube.com/playlist?list=PLCN-ZDfs33CvTXEqtvFKLQ74P2KASVtHz).



 

 

 

 

 

 

 

 [![Gilead Sciences](/sites/default/files/Clients/gilead_logo.png)](/profiles/gilead-sciences)

 



 

### More from Gilead Sciences

###### [Looking Back to the Future: Gilead’s Long-Standing Commitment To Help End the HIV Epidemic](/news/looking-back-future-gileads-long-standing-commitment-help-end-hiv-epidemic)

 Jul 23, 2025 9:45 AM ET

  



###### [Gilead Sciences - Born With HIV in the 80s: Kim’s Story of Growing Up as a Dandelion](/news/gilead-sciences-born-hiv-80s-kims-story-growing-dandelion)

 Jun 24, 2025 8:55 AM ET

  



###### [Gilead Researcher Awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award](/news/gilead-researcher-awarded-aaas-mani-l-bhaumik-breakthrough-year-award)

 Jun 17, 2025 8:50 AM ET

  



###### [Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of “The Centrifuge Sessions”](/news/gilead-sciences-advancing-new-ways-help-end-hiv-epidemic-focus-installment-centrifuge-sessions)

 Jun 5, 2025 8:50 AM ET

  



###### ["The Adventure Jar” - A Children’s Book Supporting Families Impacted by Metastatic Breast Cancer (MBC) Receives Two 2025 Bronze Anvil Awards](/news/adventure-jar-childrens-book-supporting-families-impacted-metastatic-breast-cancer-mbc)

 Jun 3, 2025 8:40 AM ET

  



###### [Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden](/news/gilead-sciences-commemorated-opening-bay-area-young-survivors-breast-cancer-memorial-garden)

 May 30, 2025 9:05 AM ET

  



###### [Transforming How Cancer Is Treated: Research Results To Be Shared at ASCO25](/news/transforming-how-cancer-treated-research-results-be-shared-asco25)

 May 29, 2025 8:20 AM ET

  



###### [Gilead Sciences and Kite Pharma To Announce Transformative Cancer Research at This Year’s American Society of Clinical Oncology (ASCO) Annual Meeting](/news/gilead-sciences-and-kite-pharma-announce-transformative-cancer-research-years-american-society)

 May 27, 2025 8:40 AM ET